Externalization: Maximizing R&D Opportunities While Minimizing IP and Data Security Risks

This month AstraZeneca announced a move towards externalizing its business model and working with partners in a bid to reduce research and development (R&D) spend. It’s a sign of the times, as the pharma and biotech industries find themselves under significant budget…